Coppell Advisory Solutions’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,641
Closed -$149K 587
2024
Q4
$149K Sell
1,641
-36
-2% -$3.44K 0.02% 333
2024
Q3
$174K Sell
1,677
-20
-1% -$2.04K 0.03% 308
2024
Q2
$165K Buy
+1,697
New +$157K 0.03% 296
2023
Q4
$129K Buy
1,617
+350
+28% +$26.3K 0.03% 325
2023
Q3
$99.9K Buy
1,267
+1,124
+786% +$84K 0.03% 218
2023
Q2
$10.9K Buy
+143
New +$11.1K ﹤0.01% 672
2023
Q1
Sell
-1,171
Closed -$92.3K 357
2022
Q4
$92.3K Buy
+1,171
New +$87.8K 0.03% 226

Other funds holding CL

Coppell Advisory Solutions's CL Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 1,641 shares — an estimated $149K sold.

Coppell Advisory Solutions first reported a position in CL in Q4 2022 and held it in 7 quarters. The position peaked at $174K in Q3 2024. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 1,641 Colgate-Palmolive shares in Q1 2025, an estimated $149K.
  • Coppell Advisory Solutions first reported a position in Colgate-Palmolive in Q4 2022 and held it in 7 quarters.
  • Coppell Advisory Solutions's Colgate-Palmolive position peaked at $174K in Q3 2024.
  • 1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.